Global Healthcare Industry Strategic Research Report 2026-2031

Publication ID:

NAV0826028

Publication Date:

August 28, 2026

Pages:

280

Countries:

Global [1]

The global healthcare services industry recorded an estimated $8,911.9 billion in base-year 2025 revenues, derived as the arithmetic mean of four independently published market research estimates that converge narrowly within a $8.6-$9.1 trillion range, providing a statistically robust and methodologically defensible baseline for this report's forward projections. This report defines the healthcare services industry as the delivery, payment, and distribution of healthcare services -- deliberately excluding pharmaceutical manufacturing and medical device manufacturing, which are covered as separate mother reports, to avoid double-counting the same economic activity across three related industry-wide reports. The industry's historical growth trajectory through 2022-2024 compounded at approximately 4.4-4.9% annually, from an estimated $7,779.7 billion in 2022 to $8,495.6 billion in 2024, anchored by fundamentally non-cyclical, demographically-driven demand.

The 2022-2026 M&A cycle in healthcare has been characterized by two themes: vertical integration deepening within the U.S. payer segment, and targeted capability acquisition in data, analytics, and home-based care. UnitedHealth Group's 2022 acquisition of Change Healthcare, a major health data and claims-processing network, significantly expanded Optum's data infrastructure and created one of the largest health data repositories in the world, though it subsequently drew ongoing antitrust attention reflecting regulators' increasing focus on data-layer consolidation in healthcare. CVS Health completed its Oak Street Health acquisition in May 2023 for approximately $10.6 billion, adding a network of value-based primary care clinics oriented toward Medicare patients, and also completed the acquisition of Signify Health in early 2023, adding in-home health evaluation capabilities aligned with the structural shift toward home-based care delivery.

Scope of Global Healthcare Industry Strategic Research Report 2026-2031

This report provides forecast data by value for the global healthcare services industry, with 2025 as the base year and forecasting to 2031.
This report provides segmentation by service type (Hospitals & Outpatient Care Centers, Physicians & Other Health Practitioners, Home Health Care & Residential Nursing Care, Medical & Diagnostic Laboratory Services, Dental Services, Residential Substance Abuse & Mental Health Facilities) and by care delivery model (Inpatient Services, Outpatient/Ambulatory Services, Home-Based Care, Telehealth/Virtual Care, Preventive & Wellness Care).
This report provides region-wise and country-level forecast data across 5 regions and 16 countries.
This report identifies key growth drivers and inhibitors, including population aging, the structural shift toward home-based and virtual care, and elevated medical cost trend pressure on payers.
This report provides company profiles for the 25 leading healthcare companies, each covering Company Overview, Key Products & Segments, Financial Performance, Business Strategy, SWOT Analysis, and Strategic Implications.
This report provides Porter's Five Forces, PESTLE, and SWOT analysis.
This report identifies key future trends through 2031.

Segment by Type

Hospitals & Outpatient Care Centers
Physicians & Other Health Practitioners
Home Health Care & Residential Nursing Care
Medical & Diagnostic Laboratory Services
Dental Services
Residential Substance Abuse & Mental Health Facilities

Segment by Application

Inpatient Services
Outpatient/Ambulatory Services
Home-Based Care
Telehealth/Virtual Care
Preventive & Wellness Care

Segment by Region

North America (United States, Canada, Rest of North America)
Europe (Germany, United Kingdom, France, Italy, Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
Latin America (Brazil, Mexico, Rest of Latin America)
Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)

Who Can Use the Global Healthcare Industry Strategic Research Report?

This research report is ideal for people who wish to gain a thorough understanding of the healthcare services market. Some of the intended users are:

C-level executives and Company Directors at health insurers, hospital systems, and healthcare distributors
Investment managers, Financial professionals, and Healthcare sector equity analysts
Healthcare policy analysts and government affairs professionals tracking reimbursement and regulatory policy
Hospital and health system administrators evaluating competitive positioning and market trends
Anyone operating in the global healthcare services value chain

Executive Summary
1. 1.1 Market Synopsis
2. 1.2 Key Findings
3. 1.3 Strategic Recommendations
4. 1.4 Report Structure and Methodology
Industry Overview & Forecast
1. 2.1 Market Definition & Scope
2. 2.2 Market Value Forecast, 2025–2031
3. 2.2.1 Base-Year Anchor and Source Convergence
4. 2.2.2 The Forecast Trajectory: 2025–2031
5. 2.2.3 Vendor-Tier Composition of the Market
6. 2.3 Historical Market Review, 2022–2024
7. 2.3.1 Growth Through the Historic Period
8. 2.3.2 Drivers of Historical Growth
9. 2.3.3 Historical Vendor-Tier Detail
10. 2.4 Market Value Segmentation Overview
11. 2.4.1 Composition by Service Type
12. 2.4.2 Composition by Care Delivery Model
13. 2.5 Regional Market Overview
14. 2.5.1 Global Regional Distribution
15. 2.6 Forecast Confidence and Data Quality Assessment
Market Segmentation by Type
1. 3.1 Segmentation Overview
2. 3.2 Hospitals & Outpatient Care Centers — The Largest, Gradually Ceding Segment
3. 3.3 Physicians & Other Health Practitioners — Stable and Substantial
4. 3.4 Home Health Care & Residential Nursing Care — The Fastest-Growing Category
5. 3.5 Medical & Diagnostic Laboratory Services — Steady Expansion Underpinned by Technology
6. 3.6 Dental Services — Stable, Structurally Differentiated
7. 3.7 Residential Substance Abuse & Mental Health Facilities — Modest Growth with Structural Tailwinds
8. 3.8 Ambulance Services — Residual Segment, Stable Profile
9. 3.9 Cross-Segment Synthesis
Market Segmentation by Application
1. 4.1 Section Overview
2. 4.2 Segmentation Framework and Analytical Rationale
3. 4.3 Inpatient Services
4. 4.3.1 Market Position and Scale
5. 4.3.2 Structural Dynamics and Pressures
6. 4.3.3 Competitive Landscape Implications
7. 4.3.4 Forward Outlook
8. 4.4 Outpatient/Ambulatory Services
9. 4.4.1 Market Position and Scale
10. 4.4.2 Structural Dynamics and Growth Drivers
11. 4.4.3 Competitive Landscape Implications
12. 4.4.4 Forward Outlook
13. 4.5 Home-Based Care
14. 4.5.1 Market Position and Scale
15. 4.5.2 Structural Dynamics and Growth Drivers
16. 4.5.3 Geographic Considerations
17. 4.5.4 Competitive Landscape Implications
18. 4.5.5 Forward Outlook
19. 4.6 Telehealth/Virtual Care
20. 4.6.1 Market Position and Scale
21. 4.6.2 Post-Pandemic Normalisation and Demand Trajectory
22. 4.6.3 Segment Architecture and Service Categories
23. 4.6.4 Competitive Landscape Implications
24. 4.6.5 Forward Outlook
25. 4.7 Preventive & Wellness Care
26. 4.7.1 Market Position and Scale
27. 4.7.2 Growth Drivers and Policy Context
28. 4.7.3 Forward Outlook
29. 4.8 Other: Specialty, Long-Term, and Palliative Care
30. 4.8.1 Market Position and Residual Role
31. 4.9 Cross-Segment Synthesis and Strategic Implications
32. 4.9.1 The Central Structural Theme: Disaggregation of the Hospital
33. 4.9.2 The Technology Layer as Enabler
34. 4.9.3 Payer-Provider Integration as Competitive Response
35. 4.9.4 Regional Differentiation in Segment Mix
36. 4.10 Summary of Segment Performance
Regional Market Forecast
1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East & Africa
Country-Level Market Forecast
1. 6.1 North America
2. 6.1.1 United States
3. 6.1.2 Canada
4. 6.1.3 Rest of North America
5. 6.2 Europe
6. 6.2.1 Germany
7. 6.2.2 United Kingdom
8. 6.2.3 France
9. 6.2.4 Italy
10. 6.2.5 Rest of Europe
11. 6.3 Asia-Pacific
12. 6.3.1 China
13. 6.3.2 Japan
14. 6.3.3 India
15. 6.3.4 South Korea
16. 6.3.5 Australia
17. 6.3.6 Rest of Asia Pacific
18. 6.4 Latin America
19. 6.4.1 Brazil
20. 6.4.2 Mexico
21. 6.4.3 Rest of Latin America
22. 6.5 Middle East & Africa
23. 6.5.1 Saudi Arabia
24. 6.5.2 UAE
25. 6.5.3 South Africa
26. 6.5.4 Rest of Middle East and Africa
Growth Drivers & Inhibitors
1. 7.1 Structural Growth Drivers
2. 7.1.1 Demographic Aging as the Primary Demand Engine
3. 7.1.2 Structural Shift Toward Home-Based and Virtual Care Delivery
4. 7.1.3 Artificial Intelligence Adoption in Clinical and Administrative Workflows
5. 7.2 Market Restraints and Inhibitors
6. 7.2.1 Elevated Medical Cost Trends and Payer Margin Compression
7. 7.2.2 Provider Operational Cost Escalation and Margin Degradation
8. 7.2.3 Value-Chain Revenue Overlap and Market Sizing Complexity
9. 7.3 Opportunity and White-Space Assessment
10. 7.3.1 Home-Based and Remote Patient Monitoring Expansion
11. 7.3.2 Retailisation of Primary Care Delivery
Key Company Profiles (UnitedHealth Group, CVS Health, McKesson Corporation, Cencora (AmerisourceBergen), Cigna Group, Cardinal Health, Elevance Health (Anthem), Centene Corporation, HCA Healthcare, Humana, Fresenius Medical Care, Kaiser Permanente, Quest Diagnostics, Labcorp Holdings, Tenet Healthcare, Universal Health Services, DaVita Inc., IQVIA Holdings, Community Health Systems, Molina Healthcare, Encompass Health, Ramsay Health Care, Fresenius SE (Group), Teladoc Health, IHH Healthcare)
1. 8.1 UnitedHealth Group
2. 8.1.1 Company Overview
3. 8.1.2 Key Products & Segments
4. 8.1.3 Financial Performance (2023–2025)
5. 8.1.4 Business Strategy
6. 8.1.5 SWOT Analysis
7. 8.1.6 Strategic Implications (2025–2031)
8. 8.2 CVS Health
9. 8.2.1 Company Overview
10. 8.2.2 Key Products & Segments
11. 8.2.3 Financial Performance (2023–2025)
12. 8.2.4 Business Strategy
13. 8.2.5 SWOT Analysis
14. 8.2.6 Strategic Implications (2025–2031)
15. 8.3 McKesson Corporation
16. 8.3.1 Company Overview
17. 8.3.2 Key Products & Segments
18. 8.3.3 Financial Performance (2023–2025)
19. 8.3.4 Business Strategy
20. 8.3.5 SWOT Analysis
21. 8.3.6 Strategic Implications (2025–2031)
22. 8.4 Cencora (AmerisourceBergen)
23. 8.4.1 Company Overview
24. 8.4.2 Key Products & Segments
25. 8.4.3 Financial Performance (2023–2025)
26. 8.4.4 Business Strategy
27. 8.4.5 SWOT Analysis
28. 8.4.6 Strategic Implications (2025–2031)
29. 8.5 Cigna Group
30. 8.5.1 Company Overview
31. 8.5.2 Key Products & Segments
32. 8.5.3 Financial Performance (2023–2025)
33. 8.5.4 Business Strategy
34. 8.5.5 SWOT Analysis
35. 8.5.6 Strategic Implications (2025–2031)
36. 8.6 Cardinal Health
37. 8.6.1 Company Overview
38. 8.6.2 Key Products & Segments
39. 8.6.3 Financial Performance (2023–2025)
40. 8.6.4 Business Strategy
41. 8.6.5 SWOT Analysis
42. 8.6.6 Strategic Implications (2025–2031)
43. 8.7 Elevance Health (Anthem)
44. 8.7.1 Company Overview
45. 8.7.2 Key Products & Segments
46. 8.7.3 Financial Performance (2023–2025)
47. 8.7.4 Business Strategy
48. 8.7.5 SWOT Analysis
49. 8.7.6 Strategic Implications (2025–2031)
50. 8.8 Centene Corporation
51. 8.8.1 Company Overview
52. 8.8.2 Key Products & Segments
53. 8.8.3 Financial Performance (2023–2025)
54. 8.8.4 Business Strategy
55. 8.8.5 SWOT Analysis
56. 8.8.6 Strategic Implications (2025–2031)
57. 8.9 HCA Healthcare
58. 8.9.1 Company Overview
59. 8.9.2 Key Products & Segments
60. 8.9.3 Financial Performance (2023–2025)
61. 8.9.4 Business Strategy
62. 8.9.5 SWOT Analysis
63. 8.9.6 Strategic Implications (2025–2031)
64. 8.10 Humana
65. 8.10.1 Company Overview
66. 8.10.2 Key Products & Segments
67. 8.10.3 Financial Performance (2023–2025)
68. 8.10.4 Business Strategy
69. 8.10.5 SWOT Analysis
70. 8.10.6 Strategic Implications (2025–2031)
71. 8.11 Fresenius Medical Care
72. 8.11.1 Company Overview
73. 8.11.2 Key Products & Segments
74. 8.11.3 Financial Performance (2023–2025)
75. 8.11.4 Business Strategy
76. 8.11.5 SWOT Analysis
77. 8.11.6 Strategic Implications (2025–2031)
78. 8.12 Kaiser Permanente
79. 8.12.1 Company Overview
80. 8.12.2 Key Products & Segments
81. 8.12.3 Financial Performance (2023–2025)
82. 8.12.4 Business Strategy
83. 8.12.5 SWOT Analysis
84. 8.12.6 Strategic Implications (2025–2031)
85. 8.13 Quest Diagnostics
86. 8.13.1 Company Overview
87. 8.13.2 Key Products & Segments
88. 8.13.3 Financial Performance (2023–2025)
89. 8.13.4 Business Strategy
90. 8.13.5 SWOT Analysis
91. 8.13.6 Strategic Implications (2025–2031)
92. 8.14 Labcorp Holdings
93. 8.14.1 Company Overview
94. 8.14.2 Key Products & Segments
95. 8.14.3 Financial Performance (2023–2025)
96. 8.14.4 Business Strategy
97. 8.14.5 SWOT Analysis
98. 8.14.6 Strategic Implications (2025–2031)
99. 8.15 Tenet Healthcare
100. 8.15.1 Company Overview
101. 8.15.2 Key Products & Segments
102. 8.15.3 Financial Performance (2023–2025)
103. 8.15.4 Business Strategy
104. 8.15.5 SWOT Analysis
105. 8.15.6 Strategic Implications (2025–2031)
106. 8.16 Universal Health Services
107. 8.16.1 Company Overview
108. 8.16.2 Key Products & Segments
109. 8.16.3 Financial Performance (2023–2025)
110. 8.16.4 Business Strategy
111. 8.16.5 SWOT Analysis
112. 8.16.6 Strategic Implications (2025–2031)
113. 8.17 DaVita Inc.
114. 8.17.1 Company Overview
115. 8.17.2 Key Products & Segments
116. 8.17.3 Financial Performance (2023–2025)
117. 8.17.4 Business Strategy
118. 8.17.5 SWOT Analysis
119. 8.17.6 Strategic Implications (2025–2031)
120. 8.18 IQVIA Holdings
121. 8.18.1 Company Overview
122. 8.18.2 Key Products & Segments
123. 8.18.3 Financial Performance (2023–2025)
124. 8.18.4 Business Strategy
125. 8.18.5 SWOT Analysis
126. 8.18.6 Strategic Implications (2025–2031)
127. 8.19 Community Health Systems
128. 8.19.1 Company Overview
129. 8.19.2 Key Products & Segments
130. 8.19.3 Financial Performance (2023–2025)
131. 8.19.4 Business Strategy
132. 8.19.5 SWOT Analysis
133. 8.19.6 Strategic Implications (2025–2031)
134. 8.20 Molina Healthcare
135. 8.20.1 Company Overview
136. 8.20.2 Key Products & Segments
137. 8.20.3 Financial Performance (2023–2025)
138. 8.20.4 Business Strategy
139. 8.20.5 SWOT Analysis
140. 8.20.6 Strategic Implications (2025–2031)
141. 8.21 Encompass Health
142. 8.21.1 Company Overview
143. 8.21.2 Key Products & Segments
144. 8.21.3 Financial Performance (2023–2025)
145. 8.21.4 Business Strategy
146. 8.21.5 SWOT Analysis
147. 8.21.6 Strategic Implications (2025–2031)
148. 8.22 Ramsay Health Care
149. 8.22.1 Company Overview
150. 8.22.2 Key Products & Segments
151. 8.22.3 Financial Performance (2023–2025)
152. 8.22.4 Business Strategy
153. 8.22.5 SWOT Analysis
154. 8.22.6 Strategic Implications (2025–2031)
155. 8.23 Fresenius SE (Group)
156. 8.23.1 Company Overview
157. 8.23.2 Key Products & Segments
158. 8.23.3 Financial Performance (2023–2025)
159. 8.23.4 Business Strategy
160. 8.23.5 SWOT Analysis
161. 8.23.6 Strategic Implications (2025–2031)
162. 8.24 Teladoc Health
163. 8.24.1 Company Overview
164. 8.24.2 Key Products & Segments
165. 8.24.3 Financial Performance (2023–2025)
166. 8.24.4 Business Strategy
167. 8.24.5 SWOT Analysis
168. 8.24.6 Strategic Implications (2025–2031)
169. 8.25 IHH Healthcare
170. 8.25.1 Company Overview
171. 8.25.2 Key Products & Segments
172. 8.25.3 Financial Performance (2023–2025)
173. 8.25.4 Business Strategy
174. 8.25.5 SWOT Analysis
175. 8.25.6 Strategic Implications (2025–2031)
Competitive Landscape
1. 9.1 Competitive Landscape Overview
2. 9.1.1 Market Structure and Concentration
3. 9.1.2 Top 5 Companies by 2025 Revenue and Estimated Global Share
4. 9.1.3 Concentration Metrics and Competitive Intensity Assessment
5. 9.2 Competitive Intensity Assessment
6. 9.2.1 Tier Structure and Revenue Segmentation
7. 9.2.2 Capacity Versus Demand Dynamics
8. 9.2.3 Pricing Environment
9. 9.2.4 Barriers to Entry and Exit
10. 9.3 Key Player Strategies & Positioning
11. 9.3.1 Strategic Group Architecture
12. 9.3.2 Table
13. 9.3.3 Differentiation Strategies Across Major Players
14. 9.3.4 Geographic Strongholds
15. 9.3.5 M&A and Partnership Activity (2022–Present)
16. 9.3.6 R&D and Technology Investment Trends
17. 9.4 Competitive Dynamics & Strategic Outlook
18. 9.4.1 Emerging Competitive Threats
19. 9.4.2 Consolidation vs. Fragmentation Outlook
20. 9.4.3 Competitive Response Matrix
21. 9.4.4 Strategic Recommendations for 2025–2031
Porter's Five Forces Analysis
1. 10.1 Threat of New Entrants
2. 10.2 Bargaining Power of Buyers
3. 10.2.1 Key Factors
4. 10.2.2 Market-Specific Context
5. 10.2.3 Trend
6. 10.2.4 Strategic Implication
7. 10.3 Bargaining Power of Suppliers
8. 10.4 Threat of Substitutes
9. 10.5 Competitive Rivalry
10. 10.5.1 Key Factors
11. 10.5.2 Market-Specific Context
12. 10.5.3 Trend: Strengthening
13. 10.5.4 Strategic Implication
PESTLE Analysis
1. 11.1 Political Factors
2. 11.1.1 Government Reimbursement Policy as a Primary Economic Lever
3. 11.1.2 Policy Risk as a Structural Industry Feature
4. 11.2 Economic Factors
5. 11.2.1 Structural Demand Resilience Across Economic Cycles
6. 11.2.2 Medical Cost Inflation as a Sector-Specific Economic Pressure
7. 11.2.3 Currency and Capital Market Considerations
8. 11.3 Social and Demographic Factors
9. 11.3.1 Population Ageing as the Dominant Structural Demand Driver
10. 11.3.2 Evolving Patient Expectations and Care Setting Preferences
11. 11.3.3 Health Equity and Access Considerations
12. 11.4 Technological Factors
13. 11.4.1 Artificial Intelligence Across Clinical and Administrative Workflows
14. 11.4.2 Remote Patient Monitoring and Telehealth Infrastructure
15. 11.4.3 Interoperability and Health Data Infrastructure
16. 11.5 Legal and Regulatory Factors
17. 11.5.1 Healthcare-Specific Regulatory Complexity
18. 11.5.2 Privacy, Data Security, and Digital Health Regulation
19. 11.5.3 Antitrust and Market Consolidation Scrutiny
20. 11.6 Environmental Factors
21. 11.6.1 Healthcare's Significant Environmental Footprint
22. 11.6.2 Pharmaceutical and Medical Waste Management
23. 11.6.3 Climate Change as a Healthcare System Stressor
24. 11.7 PESTLE Summary Assessment
SWOT Analysis
1. 12.1 Strategic Position Overview
2. 12.2 Strengths
3. 12.2.1 Non-Cyclical, Demographically-Anchored Demand Base
4. 12.2.2 Scale and Integration Advantages Among Leading Operators
5. 12.2.3 Accelerating Adoption of Care Delivery Innovation
6. 12.2.4 Diversified Global Revenue Base Across Resilient Regional Markets
7. 12.3 Weaknesses
8. 12.3.1 Structural Dependence on the Hospital-Centric Revenue Model
9. 12.3.2 Payer-Provider Revenue Overlap Obscures True Competitive Position
10. 12.3.3 Workforce Constraints Limiting Capacity Expansion
11. 12.4 Opportunities
12. 12.4.1 Home-Based Care Represents the Largest Untapped Structural Growth Opportunity
13. 12.4.2 Telehealth Scalability Offers a Step-Change in Addressable Population
14. 12.4.3 Asia-Pacific Expansion as a Multi-Decade Growth Engine
15. 12.4.4 Mental Health and Substance Abuse as an Emerging High-Growth Segment
16. 12.5 Threats
17. 12.5.1 Medical Cost Trend Inflation Represents a Structural Margin Threat to the Payer Segment
18. 12.5.2 Regulatory and Policy Uncertainty Across Key Markets
19. 12.5.3 Cybersecurity and Data Privacy Risks in an Increasingly Digital Care Infrastructure
20. 12.5.4 Workforce Supply Constraints as a Capacity Growth Inhibitor
21. 12.6 Synthesis: Strategic Implications of the SWOT Profile
Future Trends & Outlook
1. 13.1 Structural Shift Toward Home-Based and Virtual Care Delivery
2. 13.2 AI-Enabled Care Delivery and Administrative Workflow Transformation
3. 13.3 Payer Consolidation and Value-Based Care Model Expansion
4. 13.4 Long-Term Structural Outlook
5. 13.4.1 Demographic Determinism and the Aging Population Imperative
6. 13.4.2 Technology-Enabled Care Delivery Evolution

List of Exhibits

2.1 Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
2.2 Exhibit 2.2: Forecast of Global (in USD Bn)
2.3 Exhibit 2.3: Forecast of North America (in USD Bn)
2.4 Exhibit 2.4: Forecast of Europe (in USD Bn)
2.5 Exhibit 2.5: Forecast of Asia-Pacific (in USD Bn)
2.6 Exhibit 2.6: Forecast of Latin America (in USD Bn)
2.7 Exhibit 2.7: Forecast of Middle East & Africa (in USD Bn)
3.8 Exhibit 3.8: Forecast of Hospitals & Outpatient Care Centers (in USD Bn)
3.9 Exhibit 3.9: Forecast of Physicians & Other Health Practitioners (in USD Bn)
3.10 Exhibit 3.10: Forecast of Home Health Care & Residential Nursing Care (in USD Bn)
3.11 Exhibit 3.11: Forecast of Medical & Diagnostic Laboratory Services (in USD Bn)
3.12 Exhibit 3.12: Forecast of Dental Services (in USD Bn)
3.13 Exhibit 3.13: Forecast of Residential Substance Abuse & Mental Health Facilities (in USD Bn)
3.14 Exhibit 3.14: Forecast of Ambulance Services (in USD Bn)
4.15 Exhibit 4.15: Forecast of Inpatient Services (in USD Bn)
4.16 Exhibit 4.16: Forecast of Outpatient/Ambulatory Services (in USD Bn)
4.17 Exhibit 4.17: Forecast of Home-Based Care (in USD Bn)
4.18 Exhibit 4.18: Forecast of Telehealth/Virtual Care (in USD Bn)
4.19 Exhibit 4.19: Forecast of Preventive & Wellness Care (in USD Bn)
4.20 Exhibit 4.20: Forecast of Other (Specialty, Long-Term & Palliative Care) (in USD Bn)
6.21 Exhibit 6.21: Forecast of North America (in USD Bn)
6.22 Exhibit 6.22: Forecast of United States (in USD Bn)
6.23 Exhibit 6.23: Forecast of Canada (in USD Bn)
6.24 Exhibit 6.24: Forecast of Rest of North America (in USD Bn)
6.25 Exhibit 6.25: Forecast of Europe (in USD Bn)
6.26 Exhibit 6.26: Forecast of Germany (in USD Bn)
6.27 Exhibit 6.27: Forecast of United Kingdom (in USD Bn)
6.28 Exhibit 6.28: Forecast of France (in USD Bn)
6.29 Exhibit 6.29: Forecast of Italy (in USD Bn)
6.30 Exhibit 6.30: Forecast of Rest of Europe (in USD Bn)
6.31 Exhibit 6.31: Forecast of Asia-Pacific (in USD Bn)
6.32 Exhibit 6.32: Forecast of China (in USD Bn)
6.33 Exhibit 6.33: Forecast of Japan (in USD Bn)
6.34 Exhibit 6.34: Forecast of India (in USD Bn)
6.35 Exhibit 6.35: Forecast of South Korea (in USD Bn)
6.36 Exhibit 6.36: Forecast of Australia (in USD Bn)
6.37 Exhibit 6.37: Forecast of Rest of Asia Pacific (in USD Bn)
6.38 Exhibit 6.38: Forecast of Latin America (in USD Bn)
6.39 Exhibit 6.39: Forecast of Brazil (in USD Bn)
6.40 Exhibit 6.40: Forecast of Mexico (in USD Bn)
6.41 Exhibit 6.41: Forecast of Rest of Latin America (in USD Bn)
6.42 Exhibit 6.42: Forecast of Middle East & Africa (in USD Bn)
6.43 Exhibit 6.43: Forecast of Saudi Arabia (in USD Bn)
6.44 Exhibit 6.44: Forecast of UAE (in USD Bn)
6.45 Exhibit 6.45: Forecast of South Africa (in USD Bn)
6.46 Exhibit 6.46: Forecast of Rest of Middle East and Africa (in USD Bn)

UnitedHealth Group, CVS Health, McKesson Corporation, Cencora (AmerisourceBergen), Cigna Group, Cardinal Health, Elevance Health (Anthem), Centene Corporation, HCA Healthcare, Humana, Fresenius Medical Care, Kaiser Permanente, Quest Diagnostics, Labcorp Holdings, Tenet Healthcare, Universal Health Services, DaVita Inc., IQVIA Holdings, Community Health Systems, Molina Healthcare, Encompass Health, Ramsay Health Care, Fresenius SE (Group), Teladoc Health, IHH Healthcare

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.